Immunotherapy Cancer Solutions

NEW YORK, NY EIN: 93-2674279

Immunotherapy Cancer Solutions is a nonprofit organization focused on Philanthropy, Voluntarism & Grantmaking, based in NEW YORK, NY. IRS filing data is available from 2023 through 2024. As of 2024, the organization holds $500 in total assets.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$500

Revenue

Net Investment Income

Expenses

About Immunotherapy Cancer Solutions

Based on IRS filings

Immunotherapy Cancer Solutions is a nonprofit organization focused on Philanthropy, Voluntarism & Grantmaking, based in NEW YORK, NY. IRS filing data is available from 2023 through 2024. As of 2024, the organization holds $500 in total assets.

Ready to take the next step with Immunotherapy Cancer Solutions?

Financial History

Multi-year comparison from IRS filings

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$0.275$0.55$0.8250000000000001$1.120232024
Metric20242023
Total Assets$500
Revenue
Expenses
Qualifying Distributions
Net Investment Income
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$0.25$0.5$0.75$10 grants20230 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 0 recipients in 2024

Grant Size Distribution

0 grants across all recorded years

<$50K$50–100K$100–250K$250–500K$500K–1M$1–5M$5M+

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Officers and directors from IRS filings

Compensation Overview

From 2024 IRS filing

From 2024 filing

NameTitleHoursCompensation
HAIM CHERADIRECTOR
DANIELLE ESHA CHERADIRECTOR
RICHARD SERUREDIRECTOR

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings.

What could you do with Immunotherapy Cancer Solutions on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities